Correction to: “Cardiovascular Safety of Romosozumab vs PTH Analogues for Osteoporosis Treatment: A Propensity-Score-Matched Cohort Study” - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Erratum: “Comparative Cardiovascular Safety of Romosozumab and PTH Analogues in Osteoporosis Management: A Propensity-Score-Matched Analysis”

  • December 17, 2024

Share

Original Source(s)

Related Content